Validity and Reliability of the 6-Minute Pegboard and Ring Test in Patients With Coronary Artery Disease
NCT ID: NCT07163741
Last Updated: 2025-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
32 participants
OBSERVATIONAL
2025-09-15
2026-09-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Value of Wearable Electrocardiogram in the Diagnosis of Coronary Artery Disease
NCT05515666
Cardiogoniometry for Early Diagnosis of Coronary Artery Disease Symptomatik
NCT01174680
Diagnostic Performance of Exercise Stress Tests for the Detection of Epicardial and Microvascular Coronary Artery Disease
NCT05231161
Research on the Diagnostic Value of Machine Learning Model Based on Clinical Data in Patients With Coronary Heart Disease
NCT05018715
Comprehensive Functional Assessments for NOCAD
NCT06175572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Within the scope of the study, at least 32 patients diagnosed with coronary artery disease (CAD) will undergo the "6-Minute Pegboard and Ring Test" (6-PBRT), which assesses upper extremity functional exercise capacity, and the upper extremity cardiopulmonary exercise test, which assesses maximal exercise capacity, on two separate days, 48 hours apart. The 6-Minute Pegboard and Ring Test will be repeated twice, 1 hour apart, by the same evaluator. Before and after the test, heart rate (HR), oxygen saturation, respiratory frequency, arm fatigue, general fatigue, and dyspnea parameters will be assessed. In the 6-PBRT, heart rate and oxygen saturation will be measured with a pulse oximeter (Soulfix Fingertip Oximeter Pulse Oxygen Meter, ABD); fatigue and dyspnea will be assessed with the Modified Borg Scale (MBS); and respiratory frequency will be assessed by counting the number of breaths taken per minute. Patients' respiratory muscle strength will be assessed using a portable oral pressure monitor (Micro Medical MicroRM, UK); respiratory function tests will be performed using a spirometer (Cosmed, Class II/Internally Powered Equipment, Italy); and peripheral muscle strength will be assessed using a portable handheld dynamometer (JTECH Power Track Commander, Baltimore, USA). Patients' quality of life will be assessed using the "Heart Quality of Life Scale in Coronary Artery Disease Patients." All assessments and tests will be explained in detail to the patient beforehand.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with coronary artery disease group
The maximal exercise capacity for the upper limb will be evaluate by CPET and performed on the arm ergometer in addition to the upper limb functional exercise capacity will be evaluate by 6 minute pegboard and ring test.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinically stable,
* Ages between 18 and 85,
* Volunteering to participate in the study will be included in the study.
Exclusion Criteria
* Those diagnosed with moderate-to-severe valvular disease,
* Those with a history of orthopedic, neurological, or pulmonary disease that could affect exercise testing and exercise capacity,
* Those with contraindications to exercise testing according to the American College of Sports Medicine (ACSM) criteria,
* Those with a history of coronary artery bypass surgery will not be included in the study.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gazi University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Meral Boşnak Güçlü
Prof. Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aslınur ÇAKIR, MSc.
Role: STUDY_CHAIR
Gazi University
Naciye Sevim, Pt.
Role: PRINCIPAL_INVESTIGATOR
Gazi University
Meral Boşnak Güçlü, Prof. Dr.
Role: STUDY_DIRECTOR
Gazi University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gazi University Faculty of Health Sciences Department of Cardiopulmonary Physiotherapy and Rehabilitation, Ankara, Çankaya 06490
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J. 2005 Jul;26(1):153-61. doi: 10.1183/09031936.05.00034505. No abstract available.
Evans JA, Whitelaw WA. The assessment of maximal respiratory mouth pressures in adults. Respir Care. 2009 Oct;54(10):1348-59.
Nashef SA, Roques F, Sharples LD, Nilsson J, Smith C, Goldstone AR, Lockowandt U. EuroSCORE II. Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5. doi: 10.1093/ejcts/ezs043. Epub 2012 Feb 29.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-1418
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.